Branchio-oculo-facial syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1297OMIM:113620Q18.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Branchio-oculo-facial syndrome (BOFS) is a rare genetic disorder characterized by a distinctive combination of branchial (cervical/infra-auricular) skin defects, ocular anomalies, and facial abnormalities. The condition is caused by mutations in the TFAP2A gene, which encodes a transcription factor critical for craniofacial and ocular development. BOFS is present from birth and affects multiple body systems, most prominently the face, eyes, ears, and skin. Key clinical features include branchial cleft sinus defects that may appear as skin-covered lesions or hemangiomatous lesions behind the ears or on the neck, ocular abnormalities such as microphthalmia (abnormally small eyes), coloboma, lacrimal duct obstruction or aplasia, and nasolacrimal duct stenosis. Characteristic facial features include a broad nasal bridge, pseudocleft of the upper lip (resembling a poorly repaired cleft lip), cleft lip and/or palate, and malformed or prominent ears. Additional findings may include premature graying of hair, renal anomalies, hearing loss (conductive or sensorineural), and dental abnormalities. There is no cure for branchio-oculo-facial syndrome. Treatment is supportive and symptom-based, often requiring a multidisciplinary approach. Surgical interventions may be needed for cleft lip/palate repair, correction of branchial defects, and management of ocular or lacrimal duct anomalies. Hearing aids or other auditory support may be necessary for individuals with hearing loss. Regular ophthalmologic, audiologic, and renal monitoring is recommended. Genetic counseling is important for affected individuals and their families given the autosomal dominant inheritance pattern.

Also known as:

Clinical phenotype terms— hover any for plain English:

Postauricular pitHP:0004464Supraauricular pitHP:0008606Nasolacrimal duct obstructionHP:0000579
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Branchio-oculo-facial syndrome.

View clinical trials →

No actively recruiting trials found for Branchio-oculo-facial syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Branchio-oculo-facial syndrome community →

No specialists are currently listed for Branchio-oculo-facial syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Branchio-oculo-facial syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Branchio-oculo-facial syndromeForum →

No community posts yet. Be the first to share your experience with Branchio-oculo-facial syndrome.

Start the conversation →

Latest news about Branchio-oculo-facial syndrome

No recent news articles for Branchio-oculo-facial syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Branchio-oculo-facial syndrome

What is Branchio-oculo-facial syndrome?

Branchio-oculo-facial syndrome (BOFS) is a rare genetic disorder characterized by a distinctive combination of branchial (cervical/infra-auricular) skin defects, ocular anomalies, and facial abnormalities. The condition is caused by mutations in the TFAP2A gene, which encodes a transcription factor critical for craniofacial and ocular development. BOFS is present from birth and affects multiple body systems, most prominently the face, eyes, ears, and skin. Key clinical features include branchial cleft sinus defects that may appear as skin-covered lesions or hemangiomatous lesions behind the e

How is Branchio-oculo-facial syndrome inherited?

Branchio-oculo-facial syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Branchio-oculo-facial syndrome typically begin?

Typical onset of Branchio-oculo-facial syndrome is neonatal. Age of onset can vary across affected individuals.